RecruitingNCT07376109

Effects of Infertility and Assisted Reproductive Technology on Sexual Function and Behavior

Effect of Infertility and Assisted Reproductive Technology (ART) on Sexual Function and Behaviour


Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

500 participants

Start Date

Feb 6, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This cross-sectional observational study examines how infertility and the use of assisted reproductive technology (ART) are related to sexual function and sexual behaviors in women seeking fertility treatment. Infertility and the stress of ART may be associated with changes in sexual desire, satisfaction, and activity. The purpose is to better understand these associations to support the sexual health and overall well-being of women undergoing fertility care. Women who are assigned female at birth, under 45 years old, diagnosed with infertility, and attending appointments at the MUHC Reproductive Centre are invited to take part. Participants will be asked to complete an anonymous questionnaire while waiting for their clinical visit. The questionnaire includes the validated Female Sexual Function Index (FSFI), which measures different aspects of sexual function, and additional questions about sexual activities, such as frequency of intercourse and other behaviors before and after fertility treatments. Participants will not provide any identifying information. Completed questionnaires will be placed in a secure collection box to protect confidentiality. Data from approximately 500 participants will be analyzed to explore how infertility type (primary vs. secondary), duration of infertility, and the number of unsuccessful ART cycles relate to sexual function and behavior. Findings from this study may help healthcare providers better recognize and address the sexual health concerns of women with infertility. This study is approved by the McGill University Health Centre Research Ethics Board (REB #2025-11459).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 44 Years

Inclusion Criteria5

  • Assigned female at birth.
  • Self-identify as a woman.
  • Age 18-44 years.
  • Diagnosis of infertility.
  • Seeking fertility treatment at the MUHC Reproductive Centre.

Exclusion Criteria5

  • Assigned male at birth.
  • Age 45 years or older.
  • Sexual practices that do not allow for the possibility of conception (e.g., same-sex relationships without use of assisted reproductive technologies).
  • Seeking oocyte cryopreservation.
  • Individuals who do not wish to complete the anonymous questionnaire.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

MUHC Reproductive Centre

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07376109


Related Trials